Drugs and Therapeutics (D & T) Committee Meeting Results for: December 2, 2009
Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
---|---|---|---|
Tyvaso | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Renvela | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Embeda | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Stelara | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Simponi | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Vivitrol | New Drug Initial Review | Removed from Agenda | Prior Approval Required |
Extavia | New Drug Initial Review | Remove Prior Approval Requirement | Prior Approval Requirement Removed |
Zenpep | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Lamictal XR | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Lamictal ODT | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Vyvanse | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Bromfed DM | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Savella | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Nascobal | New Drug Appeal | Require Prior Approval | Prior Approval Required |
Saphris | New Drug Appeal | Remove Prior Approval Requirement | Prior Approval Required |
Moxatag | New Drug Appeal | Require Prior Approval | Prior Approval Required |